Pain: Screen and Treat

Royal Marsden NHS Foundation Trust

Status and phase: Unknown; Phase 3

Conditions: Head and Neck Cancer; Pain

Treatments: Other: Intervention

Study type: Interventional

Funder types: Other

Identifiers

NCT01716780

CCR3439

Details and patient eligibility

About

This study is looking at treating cancer pain in head and neck cancer. Patients are asked in outpatients to score their worst pain on a scale of 0 to 10 in the last 24 hours. Those with a pain score of 4 and above are randomised into the study.

Patients are allocated to continue with their current care (control group) or to be reviewed by the pain/palliative care team (intervention group). At baseline questionnaires are completed on level of pain, type of pain, quality of life and anxiety/depression. Information is also collected on the analgesia they've used in the past month and basic health economics (GP/hospital visits related to pain management and treatment).

Follow up in the trial is for 3 months and consists of questionnaires as above and further collection of information on analgesic usage and health economics.

Enrollment: 156 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients attending head and neck oncology clinics
• Patients with a cancer diagnosis who are receiving anti cancer treatment or who have received anti cancer treatment
• Patients who score 4 or more on the Brief Pain Inventory numerical rating scale screening question 'worst pain in past 24 hours'

Exclusion criteria

• age below 18 years
• patients unable to respond to an English written assessment
• patients with medical conditions that could affect their mental function or level of consciousness such as stroke, or dementia
• patients who score <4 on the Brief Pain Inventory numerical rating scale screening question
• patients already under the care of a pain/palliative care service

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

156 participants in 2 patient groups

Routine care

No Intervention group

Description:

Patients allocated to the "control group" will undergo their 'usual care'; they will be given pain medication when they specifically request it or when their oncology doctor/ nurse or GP considers it appropriate to prescribe it, either at the oncology clinic visit or at any time during the course of the study.

Intervention

Experimental group

Description:

Patients allocated to the "intervention group" will be reviewed by the pain/palliative care team and will undergo prospective, proactive, integrated, structured pain treatment according to recent guidelines on cancer pain care.

Treatment:

Other: Intervention